Alexis D. Ritvo, D. E. Foster, Christy Huff, A. J. Reid Finlayson, Bernard Silvernail & Peter R. Martin. (2023) Long-term consequences of benzodiazepine-induced neurological dysfunction: A survey. PLOS ONE 18:6, pages e0285584.
Crossref
Carrie M. Silvernail & Steven L. Wright. (2022) Surviving Benzodiazepines: A Patient’s and Clinician’s Perspectives. Advances in Therapy 39:5, pages 1871-1880.
Crossref
Edward K. Silberman. (2022) Stigmatization of Benzodiazepines: Pharmacologic and Nonpharmacologic Contributions. Psychotherapy and Psychosomatics 91:5, pages 304-306.
Crossref
Maurice Wilde, Volker Auwärter & Bjoern Moosmann. (2021) New psychoactive substances—Designer benzodiazepines. WIREs Forensic Science 3:6.
Crossref
Christine Soong, Lisa Burry, Maria Greco & Cara Tannenbaum. (2021) Advise non-pharmacological therapy as first line treatment for chronic insomnia. BMJ, pages n680.
Crossref
Jeffrey Gold. (2020) Approaches to managing benzodiazepines. Pharmacy Today 26:3, pages 41-54.
Crossref
Fiammetta Cosci & Guy Chouinard. (2020) Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications. Psychotherapy and Psychosomatics 89:5, pages 283-306.
Crossref
Alicja Lerner & Michael Klein. (2019) Dependence, withdrawal and rebound of CNS drugs: an update and regulatory considerations for new drugs development. Brain Communications 1:1.
Crossref
H. Thomas MilhornH. Thomas Milhorn. 2018. Substance Use Disorders. Substance Use Disorders
59
76
.
Domenic A. Ciraulo & Mark Oldham. 2014. The Effects of Drug Abuse on the Human Nervous System. The Effects of Drug Abuse on the Human Nervous System
499
532
.
Malcolm Lader. (2011) Benzodiazepines revisited—will we ever learn?. Addiction 106:12, pages 2086-2109.
Crossref
Bachaar Arnaout & Ismene L. Petrakis. 2011. Addiction Medicine. Addiction Medicine
511
523
.
Jean M. Bidlack & Harold H. MorrisIIIIII. (2009) Phenobarbital withdrawal seizures may occur over several weeks before remitting: Human data and hypothetical mechanism. Seizure 18:1, pages 79-81.
Crossref
Rolf van Hulten, K. Bart Teeuw, Albert Bakker & Hubert G. Leufkens. (2003) Initial 3-month usage characteristics predict long-term use of benzodiazepines: an 8-year follow-up. European Journal of Clinical Pharmacology 58:10, pages 689-694.
Crossref
David L. Laven & Lisa Oller. (2016) Drug Poisoning and Overdose for the Health Professional: Review of Select Over-the-Counter (OTC) and Prescription Medications. Journal of Pharmacy Practice 13:1, pages 37-81.
Crossref
Brian Johnson & Lance P Longo. (1998) Considerations in the Physician's Decision to Prescribe Benzodiazepines to Patients With Addiction. Psychiatric Annals 28:3, pages 160-165.
Crossref
S. Nogué, J. Nolla, L. Marruecos & P. Muriné. 1996. Human Toxicology. Human Toxicology
281
299
.
Heather Ashton. (1995) Protracted Withdrawal From Benzodiazepines: The Post-Withdrawal Syndrome. Psychiatric Annals 25:3, pages 174-179.
Crossref
Norman S Miller. (1995) Liability and Efficacy From Long-Term Use of Benzodiazepines: Documentation and Interpretation. Psychiatric Annals 25:3, pages 166-173.
Crossref
A. N. Vgontzas & A. Kales. 1995. The Pharmacology of Sleep. The Pharmacology of Sleep
503
536
.
H. Thomas MilhornH. Thomas Milhorn. 1994. Drug and Alcohol Abuse. Drug and Alcohol Abuse
255
263
.
Ronald J. Gagné. 1994. Family Medicine. Family Medicine
462
470
.
Seddon R. Savage. (1993) Addiction in the treatment of pain: Significance, recognition, and management. Journal of Pain and Symptom Management 8:5, pages 265-278.
Crossref
Jay L. Schauben. (1992) Flumazenil and precipitated benzodiazepine withdrawal reaction. Current Therapeutic Research 52:1, pages 152-159.
Crossref
James F. Buchanan, Howard E. McKinneyJr.Jr., Gregory N. Hayner & Darryl S. Inaba. 1992. Applied Therapeutics. Applied Therapeutics
1145
1173
.
P.M. Brenner, B. Wolf, Th. Rechlin, G. Kauert, E. Rüther & H. Hippius. (1991) Benzodiazepine dependence: detoxification under standardized conditions. Drug and Alcohol Dependence 29:2, pages 195-204.
Crossref
Norman S. Miller & John C. Mahler. (1991) Addiction to and dependence on benzodiazepines. Journal of Substance Abuse Treatment 8:1-2, pages 61-67.
Crossref
Steven Juergens. (1991) Alprazolam and diazepam: Addiction potential. Journal of Substance Abuse Treatment 8:1-2, pages 43-51.
Crossref
Heather Ashton. (1991) Protracted withdrawal syndromes from benzodiazepines. Journal of Substance Abuse Treatment 8:1-2, pages 19-28.
Crossref
Bruce Alexander & Paul J. Perry. (1991) Detoxification from benzodiazepines: Schedules and strategies. Journal of Substance Abuse Treatment 8:1-2, pages 9-17.
Crossref
Norman S. Miller & Mark S. Gold. (1991) Introduction benzodiazepines: A major problem. Journal of Substance Abuse Treatment 8:1-2, pages 3-7.
Crossref
Norman S. Miller & Mark S. GoldNorman S. Miller & Mark S. Gold. 1991. Alcohol. Alcohol
181
198
.
Norman S. MillerNorman S. Miller. 1991. The Pharmacology of Alcohol and Drugs of Abuse and Addiction. The Pharmacology of Alcohol and Drugs of Abuse and Addiction
327
333
.
Norman S. MillerNorman S. Miller. 1991. The Pharmacology of Alcohol and Drugs of Abuse and Addiction. The Pharmacology of Alcohol and Drugs of Abuse and Addiction
133
151
.
William K. Chiang & Lewis R. Goldfrank. (1990) Substance Withdrawal. Emergency Medicine Clinics of North America 8:3, pages 613-631.
Crossref
Paul G. McDonough, Guy E. Abraham & Joel T. Hargrove. (1990) Diagnosis and Treatment of Premenstrual Syndrome. Fertility and Sterility 54:1, pages 178-179.
Crossref
Narsipur V. Ravi, Iradj Maany, William M. Burke, Vasant Dhopesh & George E. Woody. (1990) Detoxification with phenobarbital of alprazolam-dependent polysubstance abusers. Journal of Substance Abuse Treatment 7:1, pages 55-58.
Crossref
David E. Smith & Mim J. Landry. (1990) Benzodiazepine dependency discontinuation: Focus on the chemical dependency detoxification setting and benzodiazepine-polydrug abuse. Journal of Psychiatric Research 24, pages 145-156.
Crossref
Robert L. DuPont. (1990) A practical approach to benzodiazepine discontinuation. Journal of Psychiatric Research 24, pages 81-90.
Crossref
H. Thomas MilhornH. Thomas Milhorn. 1990. Chemical Dependence. Chemical Dependence
160
166
.
N. Müller, M. Hoehe, H.E. Klein, G. Nieberle, H.P. Kapfhammer, F. May, O.A. Müller & M. Fichter. (1989) Endocrinological studies in alcoholics during withdrawal and after abstinence. Psychoneuroendocrinology 14:1-2, pages 113-123.
Crossref
Stephen R. Onyett & Graham Turpin. (2009) Benzodiazepine Withdrawal in Primary Care: A Comparison of Behavioural Group Training and Individual Sessions. Behavioural and Cognitive Psychotherapy 16:4, pages 297-312.
Crossref
John Marks. (2012) Techniques of Benzodiazepine Withdrawal in Clinical Practice. Medical Toxicology 3:4, pages 324-333.
Crossref
B. Hanin & J. Marks. (2020) Dépendance aux benzodiazépines et syndrome de sevrage. Revue de la littérature. Psychiatry and Psychobiology 3:5, pages 347-364.
Crossref
Awni Arif & Joseph Westermeyer. 1988. Manual of Drug and Alcohol Abuse. Manual of Drug and Alcohol Abuse
211
231
.
Malcolm Lader & Sandra File. (2009) The biological basis of benzodiazepine dependence1. Psychological Medicine 17:03, pages 539.
Crossref
G. K. Shaw, S. K. Majumdar, S. Waller, J. MacGarvie & G. Dunn. (2018) Tiapride in the Long-term Management of Alcoholics of Anxious or Depressive Temperament. British Journal of Psychiatry 150:2, pages 164-168.
Crossref
Paul J. Perry & Bruce Alexander. (2017) Sedative/Hypnotic Dependence: Patient Stabilization, Tolerance Testing, and Withdrawal. Drug Intelligence & Clinical Pharmacy 20:7-8, pages 532-537.
Crossref
C. Allgulander. (2007) History and current status of sedative‐hypnotic drug use and abuse. Acta Psychiatrica Scandinavica 73:5, pages 465-478.
Crossref
M. Philipp & R. Buller. 1986. Benzodiazepine. Benzodiazepine
234
241
.
H. de Wit, E. H. Uhlenhuth & C. E. Johanson. (1985) Drug preference in normal volunteers: Effects of age and time of day. Psychopharmacology 87:2, pages 186-193.
Crossref
Paul J. Perry & Christopher S. Conner. (2017) Assessment of Addiction Liability of Benzodiazepines and Buspirone. Drug Intelligence & Clinical Pharmacy 19:9, pages 657-659.
Crossref
John Marks. 1985. The Benzodiazepines: Current Standards for Medical Practice. The Benzodiazepines: Current Standards for Medical Practice
67
86
.
David E. Smith & John Marks. 1985. The Benzodiazepines: Current Standards for Medical Practice. The Benzodiazepines: Current Standards for Medical Practice
179
199
.
David E. Smith. (1984) Benzodiazepine dependence potential: Current studies and trends. Journal of Substance Abuse Treatment 1:3, pages 163-167.
Crossref